(Reuters) – Medical device maker Boston Scientific topped Wall Street expectations for third-quarter profit on Thursday, helped by a resilient demand for its heart devices following the post-pandemic rebound in elective surgeries.
On an adjusted basis, Boston Scientific earned 50 cents per share in the quarter, compared with analysts’ average estimate of 48 cents per share, according to LSEG data.
(Reporting by Christy Santhosh and Mariam Sunny in Bengaluru; Editing by Vinay Dwivedi)
